Literature DB >> 16275542

False positivity for Aspergillus antigenemia related to the administration of piperacillin/tazobactam.

Mine Durusu Tanriover1, Gökhan Metan, Belgin Altun, Gulsen Hascelik, Omrum Uzun.   

Abstract

BACKGROUND: Invasive aspergillosis is a challenge to the internist, and difficulties diagnosing the disease remain an everlasting problem.
METHODS: We reviewed the data of 65 patients with hematological malignancies and aplastic anemia who were tested for the galactomannan (GM) antigen of Aspergillus between March and November 2003.
RESULTS: GM antigen levels were false-positive in at least two consecutive samples in 5 out of 23 patients who did not have evidence of invasive aspergillosis (false positivity rate of 21.7%) but who received concomitant piperacillin/tazobactam (P/T) compared to 0 of 28 patients who did not. DISCUSSION: The use of P/T in febrile, neutropenic patients decreases the specificity of GM antigen testing, which may lead to incorrect and unnecessary attempts at diagnosis and therapy.

Entities:  

Year:  2005        PMID: 16275542     DOI: 10.1016/j.ejim.2005.04.007

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  7 in total

1.  The interaction between piperacillin-tazobactam and Aspergillus galactomannan antigenemia assay: is the story over?

Authors:  G Metan
Journal:  Infection       Date:  2012-09-07       Impact factor: 3.553

2.  Generic piperacillin/tazobactam is not associated with galactomannan false-positivity in adult patients with cancer: a case-control study.

Authors:  J-H Ko; K R Peck; W J Lee; J Y Lee; S Y Cho; Y E Ha; C-I Kang; D R Chung; C W Jung; E-S Kang; J-H Song
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-17       Impact factor: 3.267

3.  Empyema necessitatis due to Aspergillus fumigatus.

Authors:  Hyun Woo Lee; Yeon Wook Kim; Jaeyoung Cho; Chang-Hoon Lee
Journal:  BMJ Case Rep       Date:  2014-12-01

4.  The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.

Authors:  G Metan; C Ağkuş; H Buldu; A N Koç
Journal:  Infection       Date:  2010-03-17       Impact factor: 3.553

5.  Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance.

Authors:  E Fréalle; K Decrucq; F Botterel; B Bouchindhomme; D Camus; E Dei-Cas; J M Costa; I Yakoub-Agha; S Bretagne; L Delhaes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-02       Impact factor: 3.267

6.  Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.

Authors:  Hangyong He; Lin Ding; Bing Sun; Fang Li; Qingyuan Zhan
Journal:  Crit Care       Date:  2012-07-27       Impact factor: 9.097

7.  Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases.

Authors:  Gökhan Metan; Hayati Demiraslan; Leyla Gül Kaynar; Gökmen Zararsız; Emine Alp; Bülent Eser
Journal:  Braz J Infect Dis       Date:  2013-02-26       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.